⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Mission Pharmacal Company and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Mission Pharmacal Company
↗San Antonio, Texas, USA
Mission Pharmacal Company is a family-owned, privately held pharmaceutical company based in San Antonio, Texas. Founded in 1946, the company focuses on developing, manufacturing, and commercializing high-quality prescription, over-the-counter (OTC) products, and dietary supplements, with a strong emphasis on women's health, urology, and dermatology.
Beyond its branded portfolio, Mission Pharmacal operates extensive Contract Development and Manufacturing Organization (CDMO) services from its facilities in Boerne, Texas. The company is committed to identifying unmet healthcare needs and delivering innovative solutions through rigorous manufacturing standards and a patient-centric approach.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Women's Health, Urology, Dermatology
SIZE & FINANCIALS
Employees:201-500
Revenue:$100M-$150M
Founded:1946
Ownership:private
Status:operating
FUNDING
Investors:Gordon Brothers
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:TriLogic Pharma (Drug delivery platform collaboration)
COMPETITION
Position:Niche Player
Competitors:Glenmark Pharmaceuticals, Bayer, Pfizer, Novartis
LEADERSHIP
Key Executives:
Neill Walsdorf - CEO
Tom Dooley - CFO
Max Martin - COO
LINKS
Website:missionpharmacal.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Mission Pharmacal Company. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.